• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从一名携带p.Asn1303Lys(N1303K)突变的囊性纤维化患者中生成诱导多能干细胞系(MHHi018-A)。

Generation of an induced pluripotent stem cell line (MHHi018-A) from a patient with Cystic Fibrosis carrying p.Asn1303Lys (N1303K) mutation.

作者信息

Merkert Sylvia, Schubert Madline, Haase Alexandra, Janssens Hettie M, Scholte Bob, Lachmann Nico, Göhring Gudrun, Martin Ulrich

机构信息

Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), REBIRTH-Research Center for Translational and Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), Member of the German Center for Lung Research (DZL), 30625 Hannover, Germany.

Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), REBIRTH-Research Center for Translational and Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), Member of the German Center for Lung Research (DZL), 30625 Hannover, Germany.

出版信息

Stem Cell Res. 2020 Apr;44:101744. doi: 10.1016/j.scr.2020.101744. Epub 2020 Mar 25.

DOI:10.1016/j.scr.2020.101744
PMID:32220772
Abstract

Cystic Fibrosis (CF) is a genetic disease caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene which encodes for a chloride ion channel regulating the balance of salt and water across secretory epithelia. Here we generated an iPSC line from a CF patient homozygous for the p.Asn1303Lys mutation, a Class II folding defect mutation. This iPSC line provides a useful resource for disease modeling and to investigate the pharmacological response to CFTR modulators in iPSC derived epithelia.

摘要

囊性纤维化(CF)是一种由囊性纤维化跨膜传导调节因子(CFTR)基因突变引起的遗传性疾病,该基因编码一种氯离子通道,调节分泌上皮细胞中盐和水的平衡。在此,我们从一名患有p.Asn1303Lys突变(一种II类折叠缺陷突变)的纯合CF患者中生成了一条诱导多能干细胞(iPSC)系。这条iPSC系为疾病建模以及研究iPSC衍生上皮细胞对CFTR调节剂的药理反应提供了有用的资源。

相似文献

1
Generation of an induced pluripotent stem cell line (MHHi018-A) from a patient with Cystic Fibrosis carrying p.Asn1303Lys (N1303K) mutation.从一名携带p.Asn1303Lys(N1303K)突变的囊性纤维化患者中生成诱导多能干细胞系(MHHi018-A)。
Stem Cell Res. 2020 Apr;44:101744. doi: 10.1016/j.scr.2020.101744. Epub 2020 Mar 25.
2
Generation of an induced pluripotent stem cell line (IGGi002A) from nasal cells of a cystic fibrosis patient homozygous for the G542X-CFTR mutation.从一位 G542X-CFTR 突变纯合的囊性纤维化患者的鼻腔细胞中诱导生成多能干细胞系(IGGi002A)。
Stem Cell Res. 2023 Oct;72:103232. doi: 10.1016/j.scr.2023.103232. Epub 2023 Oct 18.
3
Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.使用多能干细胞衍生的人胰腺导管上皮细胞建立囊性纤维化模型。
Stem Cells Transl Med. 2016 May;5(5):572-9. doi: 10.5966/sctm.2015-0276. Epub 2016 Mar 31.
4
Generation of human induced pluripotent stem cells from cystic fibrosis patient carrying nonsense mutation (p.S308X) in CFTR gene.从携带CFTR基因无义突变(p.S308X)的囊性纤维化患者中生成人类诱导多能干细胞。
Stem Cell Res. 2022 Apr;60:102683. doi: 10.1016/j.scr.2022.102683. Epub 2022 Jan 20.
5
Generation of a gene-corrected isogenic control iPSC line from cystic fibrosis patient-specific iPSCs homozygous for p.Phe508del mutation mediated by TALENs and ssODN.通过TALENs和单链寡脱氧核苷酸介导,从携带p.Phe508del突变纯合的囊性纤维化患者特异性诱导多能干细胞中生成基因校正的同基因对照诱导多能干细胞系。
Stem Cell Res. 2017 Aug;23:95-97. doi: 10.1016/j.scr.2017.07.010. Epub 2017 Jul 11.
6
Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids.直肠囊性纤维化类器官中明显 CFTR 折叠突变体的最佳校正。
Eur Respir J. 2016 Aug;48(2):451-8. doi: 10.1183/13993003.01192-2015. Epub 2016 Apr 21.
7
Complexity of phenotypes induced by p.Asn1303Lys-CFTR correlates with difficulty to rescue and activate this protein.由p.Asn1303Lys-CFTR诱导的表型复杂性与挽救和激活该蛋白的难度相关。
Cell Mol Biol (Noisy-le-grand). 2017 Nov 30;63(11):106-110. doi: 10.14715/cmb/2017.63.11.18.
8
Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles.携带CFTR复合等位基因的囊性纤维化患者的基因型-表型相关性及功能研究。
J Med Genet. 2017 Apr;54(4):224-235. doi: 10.1136/jmedgenet-2016-103985. Epub 2016 Oct 13.
9
Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.突破性疗法:囊性纤维化(CF)增强剂和校正剂。
Pediatr Pulmonol. 2015 Oct;50 Suppl 40(0 40):S3-S13. doi: 10.1002/ppul.23240. Epub 2015 Jun 19.
10
Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.由 Q1412X 突变引起的 CFTR 门控缺陷的结构机制,该突变是囊性纤维化的一种严重的 VI 类致病性突变。
J Physiol. 2019 Jan;597(2):543-560. doi: 10.1113/JP277042. Epub 2018 Dec 2.

引用本文的文献

1
Human-based complex models: their promise and potential for rare disease therapeutics.基于人类的复杂模型:它们在罕见病治疗中的前景与潜力。
Front Cell Dev Biol. 2025 Jan 27;13:1526306. doi: 10.3389/fcell.2025.1526306. eCollection 2025.
2
Primary Ciliary Dyskinesia Patient-Specific hiPSC-Derived Airway Epithelium in Air-Liquid Interface Culture Recapitulates Disease Specific Phenotypes In Vitro.原发性纤毛运动障碍患者特异性 hiPSC 衍生气道上皮细胞在气液界面培养中体外再现疾病特异性表型。
Cells. 2023 May 24;12(11):1467. doi: 10.3390/cells12111467.
3
Induced pluripotent stem cell-based therapies for organ fibrosis.
基于诱导多能干细胞的器官纤维化治疗方法。
Front Bioeng Biotechnol. 2023 May 18;11:1119606. doi: 10.3389/fbioe.2023.1119606. eCollection 2023.
4
Generation of Human iPSC from Small Volume Peripheral Blood Samples.从小体积外周血样本中生成人类 iPSC。
Methods Mol Biol. 2022;2429:27-39. doi: 10.1007/978-1-0716-1979-7_3.